ReCode Combines With TranscripTx, Raises $80m For Novel RNA Drugs

Molecule of DNA forming inside the test tube equipment.3d rendering,conceptual image.
ReCode's LNP platform can deliver RNA therapeutics and other genetic medicines • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Start-Ups & SMEs

More from Business